// App-Quantinova.ai

T1206 2016 AHA : Sphingosine 1-Phosphate Possesses the Carrier-dependent Effects on the Plasminogen Activator Inhibitor 1 Expression in Adipocytes

Researchers

Presenter

  • Makoto Kurano

Principal Investigators

  • Masako Nishikawa

  • Kuniyuki Kano

  • Tomotaka Dohi

  • Katsumi Miyauchi

  • Hiroyuki Daida

  • Tomo Shimizu

  • Junken Aoki

  • Yutaka Yatomi

Medical Centers

  • Juntendo Univ Graduate Sch of Med, Tokyo, Japan

  • Tohoku University, Miyagi, Japan

  • The University of Tokyo, Tokyo, Japan

  • Sekisui Medical Co., Tsukuba Res Inst, Ltd, Ryu-gasaki, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Angina

  • Coronary Artery Disease

  • Venous thrombosis

Biomarkers

  • Plasminogen activator ihnibitor-1

  • Human albumin

  • Sphingosine-1-phosphate

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim